Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 7;7(8):2719-2727.
doi: 10.1534/g3.117.041277.

Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens

Affiliations

Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens

Traver Hart et al. G3 (Bethesda). .

Abstract

The adaptation of CRISPR/SpCas9 technology to mammalian cell lines is transforming the study of human functional genomics. Pooled libraries of CRISPR guide RNAs (gRNAs) targeting human protein-coding genes and encoded in viral vectors have been used to systematically create gene knockouts in a variety of human cancer and immortalized cell lines, in an effort to identify whether these knockouts cause cellular fitness defects. Previous work has shown that CRISPR screens are more sensitive and specific than pooled-library shRNA screens in similar assays, but currently there exists significant variability across CRISPR library designs and experimental protocols. In this study, we reanalyze 17 genome-scale knockout screens in human cell lines from three research groups, using three different genome-scale gRNA libraries. Using the Bayesian Analysis of Gene Essentiality algorithm to identify essential genes, we refine and expand our previously defined set of human core essential genes from 360 to 684 genes. We use this expanded set of reference core essential genes, CEG2, plus empirical data from six CRISPR knockout screens to guide the design of a sequence-optimized gRNA library, the Toronto KnockOut version 3.0 (TKOv3) library. We then demonstrate the high effectiveness of the library relative to reference sets of essential and nonessential genes, as well as other screens using similar approaches. The optimized TKOv3 library, combined with the CEG2 reference set, provide an efficient, highly optimized platform for performing and assessing gene knockout screens in human cell lines.

Keywords: CRISPR/Cas9; cancer cell lines; core essential genes; genetic screens.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) List of CRISPR knockout screens used for this study. (B) Precision-recall curves for the screens in (A) using gold standards defined in Hart et al., 2014. Dashed lines represent low-performing screens that were excluded from further analysis. (C) Number of genes assayed by at least three gRNA per gene, across the 12 screens. (D) Number of genes classified as essential (BF ≥ 6, FDR ≤ 3%) across the 12 screens. (E) Fraction of screens in which a gene is classified as essential. Genes assayed in at least seven screens and essential in 85% of screens (red) are CEG2. (F) CEG2 (n = 684) is substantially larger and only overlaps CEG1 (n = 360; Hart et al. 2014) by ∼50%. (G) Functional characterization of CEG2 (Core-v2) vs. CEG1 (Core-v1).
Figure 2
Figure 2
Effect of experimental design on screen performance. (A and B) Effect of number of gRNA per gene. (A) Subsets of the Sabatini library were randomly selected and evaluated using BAGEL. The fraction of CEG2 detected is plotted as a function of the number of gRNA per gene. Error bars represent SD of 10 random samples from the Sabatini library. (B) Incremental increase in the total number of essential genes per screen vs. incremental increase in the number of gRNA per gene. (C and D) Effect of number of replicates per experiment. The TKOv1 screen in HAP1 cells and the Yusa screen in HT29 cells, each screened at multiple timepoints, were reanalyzed using all combinations of one, two, or three replicates per screen. (C) The fraction of CEG2 reference essentials identified vs. the number of replicates. (D) The incremental increase in total number of essential genes as the number of replicates is increased.
Figure 3
Figure 3
Nonessentials vs. nontargeting controls. The distribution of observed fold-changes of gRNA targeting nonessential genes (black) is compared to the distribution for nontargeting control gRNA (green), in the Sabatini screens of Jiyoye (A), K562 (B), KBM7(C), and Raji (D) cells; P-value from T-test. For reference, the fold-change of gRNA targeting essential genes is also shown (red).
Figure 4
Figure 4
Sequence signature of high-performing guides. (A) Heatmap of the guide score derived from high-performing guides in TKOv1 screens. (B) Across the TKOv1 supplemental library in the HCT116 screen, gRNA targeting CEG2 with sequence scores in the top quartile (red) are compared with gRNA with scores in the bottom quartile (blue), and guides targeting nonessential genes are shown in black. (C–F) Similar plots for TKOv1 (HeLa screen), Yusa, Sabatini, and GeCKOv2 libraries.
Figure 5
Figure 5
Evaluation of TKOv3 library. (A) Precision-recall curves of TKOv1 and TKOv3 screens in HAP1 cells. (B) Comparison of essential genes in TKOv3 vs. TKOv1 and HAP1 essentials from Blomen et al. (2015) at 5% FDR. (C) TKOv3 guides targeting essential vs. nonessential genes in HAP1. Guides targeting essential genes, with fold-change <5th percentile of guides targeting nonessential genes, are defined as active guides. (D) The fraction of active guides (active guides targeting essential genes / all guides targeting essential genes) across the five libraries tested. (E) Distribution of sequence scores for all candidate gRNA sequences (n ∼ 2.5 million) compared to published CRISPR/SpCas9 libraries. (F) Overlap of gRNA sequences in the top three libraries by sequence score.

References

    1. Aguirre A. J., Meyers R. M., Weir B. A., Vazquez F., Zhang C. Z., et al. , 2016. Genomic copy number dictates a gene-independent cell response to CRISPR-Cas9 targeting. Cancer Discov. 6: 914–929. - PMC - PubMed
    1. Blomen V. A., Majek P., Jae L. T., Bigenzahn J. W., Nieuwenhuis J., et al. , 2015. Gene essentiality and synthetic lethality in haploid human cells. Science 350: 1092–1096. - PubMed
    1. Doench J. G., Fusi N., Sullender M., Hegde M., Vaimberg E. W., et al. , 2016. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34: 184–191. - PMC - PubMed
    1. Echeverri C. J., Beachy P. A., Baum B., Boutros M., Buchholz F., et al. , 2006. Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat. Methods 3: 777–779. - PubMed
    1. Evers B., Jastrzebski K., Heijmans J. P., Grernrum W., Beijersbergen R. L., et al. , 2016. CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes. Nat. Biotechnol. 34: 631–633. - PubMed

Publication types

Substances